The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels

Gerta Hoxhaj(Harvard University), James Hughes-Hallett(Harvard University), Rebecca C. Timson(Harvard University), Erika Ilagan(Harvard University), Min Yuan(Beth Israel Deaconess Medical Center), John M. Asara(Beth Israel Deaconess Medical Center), Issam Ben‐Sahra(Northwestern University), Brendan D. Manning(Harvard University)
Cell Reports
October 1, 2017
Cited by 210Open Access
Full Text

Abstract

Mechanistic (or mammalian) target of rapamycin complex 1 (mTORC1) integrates signals from growth factors and nutrients to control biosynthetic processes, including protein, lipid, and nucleic acid synthesis. We find that the mTORC1 pathway is responsive to changes in purine nucleotides in a manner analogous to its sensing of amino acids. Depletion of cellular purines, but not pyrimidines, inhibits mTORC1, and restoration of intracellular adenine nucleotides via addition of exogenous purine nucleobases or nucleosides acutely reactivates mTORC1. Adenylate sensing by mTORC1 is dependent on the tuberous sclerosis complex (TSC) protein complex and its regulation of Rheb upstream of mTORC1, but independent of energy stress and AMP-activated protein kinase (AMPK). Even though mTORC1 signaling is not acutely sensitive to changes in intracellular guanylates, long-term depletion of guanylates decreases Rheb protein levels. Our findings suggest that nucleotide sensing, like amino acid sensing, enables mTORC1 to tightly coordinate nutrient availability with the synthesis of macromolecules, such as protein and nucleic acids, produced from those nutrients.


Related Papers

No related papers found

Powered by citation graph analysis